-+ 0.00%
-+ 0.00%
-+ 0.00%

VALNEVA REPORTS POSITIVE FINAL PHASE 2 ANTIBODY PERSISTENCE AND SAFETY RESULTS IN CHILDREN FOR ITS CHIKUNGUNYA VACCINE IXCHIQ®

路透·12/10/2025 16:45:00

登录查看新闻详情